C-U8L6OneSkin Technologies
OS-01 peptide, cellular senescence, skin aging
consumer products
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-U8L6
C-U8L6C-U8L6OS-01 peptide, cellular senescence, skin aging
0-100 chain-logic scale · 15 dimensions · scored on public evidence
OneSkin Technologies OS-01 peptide, cellular senescence, skin aging
OneSkin sells topical products for healthy aging across face, body, lip, hair, and sunscreen categories. Its R&D platform is described as in-house scientist-led product development using proprietary MolClock and Skin Age Modeling methods. The company says its OS-01 peptide reduces accumulation of senescent cells in skin and has been studied in lab, clinical, and peer-reviewed research.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
OneSkin Technologies — Early mechanism · Lower middle. Derived deterministically from 5 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic